Rallybio Corporation (RLYB) to Issue Special Dividend of $13.56 on November 13th

Rallybio Corporation (NASDAQ:RLYB) announced a special dividend on Sunday, October 25th. Investors of record on Thursday, November 5th will be given a dividend of $13.56 per share on Friday, November 13th.

Rallybio Stock Down 4.3%

RLYB stock traded down $0.72 during trading on Tuesday, hitting $15.93. 52,619 shares of the company’s stock traded hands, compared to its average volume of 123,699. The stock has a market capitalization of $84.59 million, a price-to-earnings ratio of -3.67 and a beta of -0.72. Rallybio has a 52 week low of $3.67 and a 52 week high of $17.57. The stock has a fifty day moving average price of $16.82 and a two-hundred day moving average price of $12.67.

Rallybio (NASDAQ:RLYB) last posted its quarterly earnings results on Tuesday, October 27th. The company reported ($0.48) earnings per share (EPS) for the quarter. Rallybio had a negative return on equity of 40.53% and a negative net margin of 911.07%.

About Rallybio

Rallybio Corporation is a clinical-stage biotechnology company focused on developing medicines for patients with rare diseases, with an emphasis on conditions that affect maternal and fetal health, as well as other serious disorders with limited treatment options. The company is headquartered in New Haven, Connecticut, and its programs are intended for specialized patient populations in the United States and international markets.

Rallybio’s lead program, RLYB212, is being developed to prevent fetal and neonatal alloimmune thrombocytopenia, a rare condition in which maternal antibodies attack fetal platelets during pregnancy.